Dong‐Yan Jin

Active 1997–2025

Also published as
Dong-Yan Jin
121
Papers
23,366
Citations
75
h-index
118
i10-index

Citations

Citations per year for Dong‐Yan Jin1982: 1 citations1987: 1 citations1992: 1 citations1997: 4 citations1998: 32 citations1999: 64 citations2000: 64 citations2001: 80 citations2002: 75 citations2003: 85 citations2004: 98 citations2005: 94 citations2006: 79 citations2007: 120 citations2008: 98 citations2009: 101 citations2010: 112 citations2011: 116 citations2012: 121 citations2013: 113 citations2014: 139 citations2015: 116 citations2016: 125 citations2017: 85 citations2018: 102 citations2019: 349 citations2020: 2,590 citations2021: 1,752 citations2022: 1,172 citations2023: 508 citations2024: 576 citations2025: 209 citations2026: 6 citations1983–1986: no citations, so these years are not shown1988–1991: no citations, so these years are not shown1993–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,648 citing papers, 20.9% of this breakdownChina: 1,833 citing papers, 14.5% of this breakdownUnited Kingdom: 637 citing papers, 5% of this breakdownIndia: 567 citing papers, 4.5% of this breakdownItaly: 489 citing papers, 3.9% of this breakdownHong Kong: 474 citing papers, 3.7% of this breakdownGermany: 461 citing papers, 3.6% of this breakdownCanada: 364 citing papers, 2.9% of this breakdownFrance: 333 citing papers, 2.6% of this breakdownJapan: 302 citing papers, 2.4% of this breakdownAustralia: 278 citing papers, 2.2% of this breakdownIran: 264 citing papers, 2.1% of this breakdown
0%20.9%Other 31.7%

Fields

  • Medicine56.2%
  • Biochemistry, Genetics and Molecular Biology20.9%
  • Immunology and Microbiology7.9%
  • Mathematics4.4%
  • Computer Science2.1%
  • Agricultural and Biological Sciences2%
  • Other6.5%

Topics

  • SARS-CoV-2 and COVID-19 Research11.8%
  • COVID-19 Clinical Research Studies9.3%
  • Long-Term Effects of COVID-192.9%
  • COVID-19 epidemiological studies2.8%
  • SARS-CoV-2 detection and testing2.6%
  • interferon and immune responses2.6%
  • Other68%

Coauthors

All papers

Open in search
  1. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists

    Authors: , , , , , , , , , , , - Emerging Microbes & Infections 2020 cited by 556

  2. Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2022 cited by 222

  3. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells

    Authors: , , , , , , , , , , , , , - Emerging Microbes & Infections 2021 cited by 474

  4. Presumed Asymptomatic Carrier Transmission of COVID-19

    Authors: , , , , , , - JAMA 2020 cited by 4,859

  5. Zoonotic origins of human coronaviruses

    Authors: , , , , , - International Journal of Biological Sciences 2020 cited by 978

  6. Coronaviruses exploit a host cysteine-aspartic protease for replication

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 86

  7. Severe acute respiratory syndrome Coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3‐dependent ubiquitination of ASC

    Authors: , , , , , , , , , , - The FASEB Journal 2019 cited by 525

  8. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters

    Authors: , , , , , , , , , , , , , - Nature Microbiology 2020 cited by 198

  9. SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2019 cited by 259

  10. Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Science Advances 2021 cited by 102

  11. Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cell 2021 cited by 299

  12. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kong‐Hung Sze, Jinxia Zhang, Hin Chu, Kin‐Hang Kok, Dong Wang, Xuehui Cai, Jeffrey D. Esko, Ivan Fan‐Ngai Hung, Ronald Adolphus Li, Honglin Chen, Hongzhe Sun, Dong‐Yan Jin, Ren Sun, Sumit K. Chanda, Kwok‐Yung Yuen - Nature 2021 cited by 211

  13. Post-activation Turn-off of NF-κB-dependent Transcription Is Regulated by Acetylation of p65

    Authors: , , , , , , , , - Journal of Biological Chemistry 2003 cited by 551

  14. Suppression of cGAS- and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1

    Authors: , , , , , , - PLoS Pathogens 2023 cited by 47

  15. Interspecies transmission and emergence of novel viruses: lessons from bats and birds

    Authors: , , , , - Trends in Microbiology 2013 cited by 632

  16. Modulation of the Unfolded Protein Response by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein

    Authors: , , , , , - Journal of Virology 2006 cited by 260

  17. Recognition of Double-Stranded RNA and Regulation of Interferon Pathway by Toll-Like Receptor 10

    Authors: , , , , , , - Frontiers in Immunology 2018 cited by 91

  18. A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses

    Authors: , , , , , , , , , , , , , - Scientific Reports 2016 cited by 173

  19. Receptor Usage of a Novel Bat Lineage C Betacoronavirus Reveals Evolution of Middle East Respiratory Syndrome-Related Coronavirus Spike Proteins for Human Dipeptidyl Peptidase 4 Binding

    Authors: , , , , , , , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2018 cited by 112

  20. SARS-CoV-2 exploits host DGAT and ADRP for efficient replication

    Authors: , , , , , , , , , , , , , , - Cell Discovery 2021 cited by 54

  21. Targeting papain-like protease for broad-spectrum coronavirus inhibition

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Protein & Cell 2022 cited by 51

  22. Inhibition of AIM2 inflammasome activation by a novel transcript isoform of IFI16

    Authors: , , , , , , , , , , , , , , , - EMBO Reports 2018 cited by 89

  23. SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1

    Authors: , , , , , - Cell & Bioscience 2022 cited by 64

  24. Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients

    Authors: , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2021 cited by 387